Veritas, Luthra, Herbert, Latham lead on Claris sale of generic injectables biz to Baxter for $625 millionDecember 16 2016
Claris Lifesciences Ltd will sell its global generic injectables business to US-based Baxter International Inc. for $625 million (Rs. 4,238 crore).
Veritas Legal and AZB & Partners acted as domestic legal counsel for Claris Lifesciences while Herbert Smith acted as international counsel.
The Veritas team was led by Partners Abhijit Joshi and Tusha Raut.
The AZB team was led by Partner Anand Shah
You need to have an active subscription to view this content.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports